XML 73 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 31,167 $ 73,981
Marketable securities 73,944 22,518
Accounts receivable, net 12,103 0
Inventories 10,380 0
Research and development tax credit receivable 1,322 2,248
Prepaid expenses and other current assets 5,286 2,096
Total current assets 134,202 100,843
Property and equipment, net 585 839
Operating lease right-of-use assets 2,591 1,713
Goodwill 16,836 16,836
Research and development tax credit receivable 332 1,232
Other non-current assets 10,152 11,322
Total assets 164,698 132,785
Current liabilities:    
Current portion of long-term debt 0 37,668
Current portion of operating lease liability 934 960
Accounts payable 11,433 7,890
Accrued expenses 24,227 7,334
Other current liabilities 261 1,941
Total current liabilities 36,855 55,793
Long-term debt 0 91,614
Long-term operating lease liability 1,690 780
Royalty financing obligation 32,760 0
Other non-current liabilities 5,654 5,743
Total liabilities 76,959 153,930
Shareholders’ equity (deficit):    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 5,194 issued and outstanding at December 31, 2023 and 488 issued and outstanding at December 31, 2022 52 5
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 89,825 issued and outstanding at December 31, 2023 and 62,878 issued and outstanding at December 31, 2022 898 628
Additional paid-in capital 855,452 589,783
Accumulated deficit (745,496) (585,220)
Accumulated other comprehensive loss (23,167) (26,341)
Total shareholders’ equity (deficit) 87,739 (21,145)
Total liabilities and shareholders’ equity (deficit) $ 164,698 $ 132,785